Optos, a leading provider of devices to eye care professionals, was founded in 1992 with the mission of revolutionizing retinal imaging following a tragic incident involving a five-year-old boy. The company's optomap® retinal imaging technology has benefited millions of patients worldwide, with its products offering high-resolution images of 82% or 200◦ of the retina in a single comfortable capture. Optos' most recent innovation integrates ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT), enabling early detection and effective treatment of various retinal disorders and diseases. As a division of Nikon Co. Ltd since 2015, Optos, headquartered in the United Kingdom, has been at the forefront of advancing patient care in the Health Care and Health and Wellness industries.
There is no investment information